🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Clinical Trial to evaluate the pharmacokinetic Characteristics, safety and ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06
Trial ID
NCT07532148
EGFR-tyrosine kinase inhibitor(TKI)- ie, erlotinib, gefitinib, has been rec...
Status
Unknown
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT02066038
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of cytokin...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02487992
Treatments Being Tested
EGFR-tyrosine kinase inhibitor(TKI)- ie, erlotinib, gefitinib, icotinib,has...
Status
Unknown
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT03151161
Treatments Being Tested
This phase 1 dose-escalation and dose-expansion study is designed to evalua...
Status
Active Not Recruiting
Location
St Vincent's Hospital Sydney
Start Date
2019-07-09
Trial ID
NCT03874884
Treatments Being Tested
The aim of this study is to observe the efficacy and safety of immume check...
Status
Active Not Recruiting
Location
Henan Cancer Hospital
Start Date
2020-01-20
Trial ID
NCT03950271
Treatments Being Tested
The objective is to investigate the efficacy and safety of two-weekly alter...
Status
Unknown
Location
Jiangsu Cancer Institute & Hospital
Start Date
2019-09-01
Trial ID
NCT04324476
Treatments Being Tested
The objective of this study is to test and compare the effectiveness and co...
Status
Terminated
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT02077907